Tyra Biosciences annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Tyra Biosciences Depreciation & Amortization Growth & History (TYRA)
Tyra Biosciences's depreciation and amortization was $546,000 for fiscal 2025.
View full Tyra Biosciences company overviewTyra Biosciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $546,000 | $27,000 | +5.20% |
| 2024 | 2024-12-31 | $519,000 | $162,000 | +45.38% |
| 2023 | 2023-12-31 | $357,000 | $61,000 | +20.61% |
| 2022 | 2022-12-31 | $296,000 | $156,000 | +111.43% |
| 2021 | 2021-12-31 | $140,000 | $93,000 | +197.87% |
| 2020 | 2020-12-31 | $47,000 | — | — |
Tyra Biosciences quarterly depreciation and amortization
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $138,000 | −$2,000 | −1.43% |
| Q1 2026 | 2026-03-31 | $138,000 | −$5,000 | −3.50% |
| Q4 2025 | 2025-12-31 | $132,000 | — | — |
| Q3 2025 | 2025-09-30 | $131,000 | $4,000 | +3.15% |
| Q2 2025 | 2025-06-30 | $140,000 | $14,000 | +11.11% |
| Q1 2025 | 2025-03-31 | $143,000 | $21,000 | +17.21% |
| Q3 2024 | 2024-09-30 | $127,000 | $44,000 | +53.01% |
| Q2 2024 | 2024-06-30 | $126,000 | $37,000 | +41.57% |
| Q1 2024 | 2024-03-31 | $122,000 | $39,000 | +46.99% |
| Q3 2023 | 2023-09-30 | $83,000 | $1,000 | +1.22% |
| Q2 2023 | 2023-06-30 | $89,000 | $21,000 | +30.88% |
| Q1 2023 | 2023-03-31 | $83,000 | $19,000 | +29.69% |
| Q3 2022 | 2022-09-30 | $82,000 | $41,000 | +100.00% |
| Q2 2022 | 2022-06-30 | $68,000 | $41,000 | +151.85% |
| Q1 2022 | 2022-03-31 | $64,000 | $42,000 | +190.91% |
| Q3 2021 | 2021-09-30 | $41,000 | −$16.0M | −99.74% |
| Q2 2021 | 2021-06-30 | $27,000 | — | — |
| Q1 2021 | 2021-03-31 | $22,000 | — | — |
| Q3 2020 | 2020-09-30 | $16.0M | — | — |
Tyra Biosciences depreciation and amortization trends
Over the last five fiscal years, Tyra Biosciences's depreciation and amortization increased from $47,000 to $546,000, a change of $499,000. The latest reported quarter, Q2 2026, shows $138,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tyra Biosciences source filings ↗